Article thumbnail

Improved Functional Activity of Bone Marrow Derived Circulating Progenitor Cells After Intra Coronary Freshly Isolated Bone Marrow Cells Transplantation in Patients with Ischemic Heart Disease

By R. Goekmen Turan, I. Bozdag-T, J. Ortak, S. Kische, I. Akin, H. Schneider, C. H. Turan, T. C. Rehders, M. Rauchhaus, T. Kleinfeldt, C. Belu, M. Brehm, S. Yokus, S. Steiner, K. Sahin, C. A. Nienaber and H. Ince
Topics: Article
Publisher: Humana Press Inc
OAI identifier: oai:pubmedcentral.nih.gov:3137778
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). Adult stem cell therapy in perspective.
  2. (1986). Advantages and applications of the centreline method for characterizing regional ventricular function.
  3. (2002). Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs.
  4. (2003). Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear transplantation.
  5. (1992). Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.
  6. Assmus,B.,Schachinger,V.,Teupe,C.,etal.(2002).Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI).
  7. (2006). Autologous bone marrow-derived stem-cell transfer in patients with STsegment elevation myocardial infarction: double-blind, randomised controlled trial.
  8. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration.
  9. (2001). Bone marrow cells regenerate infarcted myocardium.
  10. (2009). Bone marrow derived pluripotent cells are pericytes which contribute to vascularization.
  11. (2002). Bone marrowderived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition.
  12. (2008). Cell-based therapy of myocardial infarction.
  13. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. The New England
  14. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. The New England
  15. (2001). Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1) 1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction.
  16. (2001). Contribution of endothelial cells of hematopoietic origin to blood vessel formation.
  17. (2004). Cytokineinduced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries.
  18. (1999). Decreased activity of the L-arginine-nitric-oxide metabolic pathway in patients with congestive heart failure.
  19. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
  20. (2007). Endothelial precursor cells.
  21. (2003). Endothelial progenitor cells, new hope for a broken heart.
  22. (2003). Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.
  23. (2003). Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation.
  24. (2004). Expression of vascular endothelial growth factor receptor-2 or tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization.
  25. (2009). Five-year followup after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy.
  26. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction.
  27. (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.
  28. (2000). In vitro differentiation of endothelial cells from AC133-positive progenitor cells.
  29. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
  30. (1997). Isolation of putative progenitor endothelial cells for angiogenesis.
  31. (2001). Mobilised bone marrow cells repair the infarcted heart, improving function and survival.
  32. (2001). Neovascularization of ischaemic myocardium by human bonemarrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.
  33. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.
  34. (2005). Plasticity and tissue regenerative potential of bone marrow-derived cells.
  35. (2006). Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo.
  36. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow.
  37. (2009). Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue.
  38. (2004). Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
  39. (2005). Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease (The IACT Study).
  40. (1996). Regression or progression. dependency on vascular nitric oxide. Arteriosclerosis, Thrombosis, and Vascular Biology,
  41. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.
  42. (1999). Serum from patients with severe heart failure down regulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha.
  43. (2002). Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.
  44. (2003). Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.
  45. (2001). The evolving concept of a stem cell: entity or function?
  46. (2002). The failing heart.
  47. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.
  48. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. The New England
  49. (2001). Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischaemia.
  50. (2002). Vascular progenitors: from biology to treatment. Trends in Cardiovascular Medicine,